Study Title
A Study to Evaluate 68Ga-P3 PET/CT Imaging of PSMA Expression in Prostate
Study Details
Description:
Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein that consists of 750 amino acids. It is highly expressed on most prostate cancer cells and neovascular endothelial cells of tumors, making PSMA a highly specific and significant imaging target for malignancies. [68Ga]P3, a novel molecular probe of PET imaging agent that targets PSMA, can be used in the diagnosis and research of a wide variety of PSMA high-expression malignanciesr.
Sponsor:
Peking University First HospitalContacts:
Xing Yang, Dr.yangxing2017@bjmu.edu.cn
+861083572928
Government Study Link:
NCT05940259 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468